Report Overview
Indian Infectious Disease Drugs Market size stood at USD XX Billion in 2019 and is projected to reach USD XX Billion by 2028, exhibiting a CAGR of XX% during the forecast period (2019-2028).
Infectious diseases are caused due to organisms such as bacteria, viruses, fungi, or parasites. The Indian market has been exhibiting significant demand for antiviral prescription drugs, especially with the wake of the coronavirus pandemic. During 2020, the regional market was estimated at $XX Billion. Increasing prevalence of the infectious diseases like TB, AIDS, and others in India is one of the major drivers for the growth of the market during the forecast period. 22% of deaths of children below the age of 5 years in India are caused due to meningitis and pneumonia.
Market Drivers
Factors such as the rising prevalence of infectious diseases and increasing awareness regarding these diseases are expected to drive the market growth.Other factors are owing of the high patient population suffering from bacterial infectious diseases and the rising number of initiatives taken by governments as well as private institutes to create awareness regarding infectious diseases.
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.